FI121599B - Menetelmä enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteiden valmistamiseksi ja näiden välituotteita - Google Patents

Menetelmä enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteiden valmistamiseksi ja näiden välituotteita Download PDF

Info

Publication number
FI121599B
FI121599B FI972620A FI972620A FI121599B FI 121599 B FI121599 B FI 121599B FI 972620 A FI972620 A FI 972620A FI 972620 A FI972620 A FI 972620A FI 121599 B FI121599 B FI 121599B
Authority
FI
Finland
Prior art keywords
group
acid
compound
formula
oxo
Prior art date
Application number
FI972620A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972620A0 (fi
FI972620L (fi
Inventor
Gary Alan Flynn
Douglas Wade Beight
Thomas Delbert Bannister
Michael James Genin
Original Assignee
Aventisub Ii Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/535,403 external-priority patent/US5641880A/en
Application filed by Aventisub Ii Inc filed Critical Aventisub Ii Inc
Publication of FI972620A0 publication Critical patent/FI972620A0/fi
Publication of FI972620L publication Critical patent/FI972620L/fi
Application granted granted Critical
Publication of FI121599B publication Critical patent/FI121599B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI972620A 1994-12-21 1997-06-18 Menetelmä enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteiden valmistamiseksi ja näiden välituotteita FI121599B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US36091594A 1994-12-21 1994-12-21
US36091594 1994-12-21
US53540395 1995-10-24
US08/535,403 US5641880A (en) 1994-12-21 1995-10-24 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
PCT/US1995/015225 WO1996019492A1 (en) 1994-12-21 1995-11-20 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US9515225 1995-11-20

Publications (3)

Publication Number Publication Date
FI972620A0 FI972620A0 (fi) 1997-06-18
FI972620L FI972620L (fi) 1997-06-18
FI121599B true FI121599B (fi) 2011-01-31

Family

ID=27001069

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972620A FI121599B (fi) 1994-12-21 1997-06-18 Menetelmä enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteiden valmistamiseksi ja näiden välituotteita

Country Status (22)

Country Link
US (1) US5734049A (da)
EP (1) EP0800527B1 (da)
JP (1) JP3658408B2 (da)
CN (2) CN1241924C (da)
AR (1) AR000378A1 (da)
AT (2) ATE190315T1 (da)
AU (1) AU689362B2 (da)
CA (2) CA2297134C (da)
DE (2) DE69533002T2 (da)
DK (2) DK0800527T3 (da)
ES (2) ES2216386T3 (da)
FI (1) FI121599B (da)
GR (1) GR3033329T3 (da)
HU (1) HU227675B1 (da)
IL (6) IL116428A (da)
MX (1) MX9704677A (da)
NO (2) NO308900B1 (da)
NZ (2) NZ298245A (da)
PT (2) PT800527E (da)
SI (2) SI0957109T1 (da)
TW (1) TW401413B (da)
WO (1) WO1996019492A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
EP2951154B1 (de) * 2013-01-30 2017-04-19 Basf Se 2,6-bis-(aminomethyl)piperidin- (2,6-bamp-), 2,6-bis-(isocyanomethyl)piperidin- (diisocyanat-) und 2,6-dicyanopiperidin-derivate (2,6-dcp-derivate) und ihre verwendung in der herstellung von epoxyharzen, polyurethanen, polyetherolen und polyamiden

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
ZA874107B (da) * 1986-06-13 1987-12-09
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
DK0492369T3 (da) * 1990-12-21 1997-10-13 Merrell Pharma Inc Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
EP0534363B1 (en) * 1991-09-27 1997-07-09 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam

Also Published As

Publication number Publication date
CN1241924C (zh) 2006-02-15
CA2297134C (en) 2004-02-10
DK0957109T3 (da) 2004-06-01
NO972875D0 (no) 1997-06-20
CN1170413A (zh) 1998-01-14
DK0800527T3 (da) 2000-06-05
HU227675B1 (en) 2011-11-28
EP0800527A1 (en) 1997-10-15
FI972620A0 (fi) 1997-06-18
CA2208569A1 (en) 1996-06-27
CA2297134A1 (en) 1996-06-27
NO972875L (no) 1997-08-20
IL139142A0 (en) 2001-11-25
NO308900B1 (no) 2000-11-13
ATE190315T1 (de) 2000-03-15
NO20001822L (no) 1997-08-20
IL139142A (en) 2004-07-25
SI0957109T1 (en) 2004-10-31
DE69515517D1 (de) 2000-04-13
JP3658408B2 (ja) 2005-06-08
GR3033329T3 (en) 2000-09-29
ATE266040T1 (de) 2004-05-15
DE69533002T2 (de) 2005-05-04
NZ334608A (en) 1999-07-29
DE69515517T2 (de) 2000-07-06
US5734049A (en) 1998-03-31
AU689362B2 (en) 1998-03-26
IL116428A (en) 2001-03-19
ES2216386T3 (es) 2004-10-16
IL139141A0 (en) 2001-11-25
DE69533002D1 (de) 2004-06-09
IL139141A (en) 2005-11-20
HUT78073A (hu) 1999-08-30
CN1495186A (zh) 2004-05-12
NO20001822D0 (no) 2000-04-07
NO310025B1 (no) 2001-05-07
IL116428A0 (en) 1996-03-31
PT957109E (pt) 2004-09-30
IL128996A0 (en) 2000-02-17
CN1113894C (zh) 2003-07-09
HK1066009A1 (en) 2005-03-11
FI972620L (fi) 1997-06-18
MX9704677A (es) 1997-09-30
CA2208569C (en) 2000-07-11
EP0800527B1 (en) 2000-03-08
TW401413B (en) 2000-08-11
WO1996019492A1 (en) 1996-06-27
AR000378A1 (es) 1997-06-18
JPH10511348A (ja) 1998-11-04
NZ298245A (en) 1999-04-29
AU4368596A (en) 1996-07-10
PT800527E (pt) 2000-06-30
ES2147863T3 (es) 2000-10-01
SI0800527T1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
JP2542213B2 (ja) 抗高血圧剤として有用な新規化合物とその製法
US5006651A (en) Phosphinic acid derivatives
JP3295848B2 (ja) 4−メルカプトアセチルアミノ−[2]ベンズアゼピノン(3)誘導体及びエンケファリナーゼ阻害剤としての用途
CA2127384A1 (en) Substituted azepino [2,1-a] isoquinoline compounds
IL190120A (en) Preparation of a history of 9-amino-octahydro-10,6-dioxo-6H-pyridazino / 2a // 2,1 / diazepine-1-carboxylic acid
FI121599B (fi) Menetelmä enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteiden valmistamiseksi ja näiden välituotteita
KR100378610B1 (ko) 엔케팔린아제및안지오텐신전환효소억제제중간체의신규한제조방법및그의중간체
EP0186586B1 (en) Cephem compounds and the production thereof
CA2222960A1 (en) Imidazo 1,5a pyridine derived serine protease inhibitors
FI110001B (fi) 6-substituoidut 5-okso-oktahydrotiatsolo[3,2-a]atsepiini-3-karboksyylihappojohdannaiset ja menetelmä niiden valmistamiseksi sekä niiden käyttö
CN87104166A (zh) 抗高血压新药

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

FG Patent granted

Ref document number: 121599

Country of ref document: FI

MM Patent lapsed